Illumina competitors.

$109.79 The fast pace of innovation in biotech is the biggest risk to Illumina's future. With a $42 billion market cap, it could sting sooner than investors think. When …Illumina top competitors include Cepheid, Bruker Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc. What industry does Illumina belongs to? Illumina is in the industry of Business Services, and also Research & Development, Manufacturing. TruSight Oncology 500 is a next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling of tumor samples. It supports identification of all relevant DNA and RNA variants implicated in various solid tumor types. In addition, it accurately measures key current immuno-oncology biomarkers: microsatellite instability ...Dec 16, 2022 · But Reuters interviews with 13 cancer researchers, genomics experts and potential competitors to Grail and Illumina show the field of winners and losers among early detection cancer test makers is ... Explore Illumina's alternatives and competitors. Axela Biosensors. Axela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics.

Illumina top competitors include Cepheid, Bruker Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc. What industry does Illumina belongs to? Illumina is in the industry of Business Services, and also Research & Development, Manufacturing.When it comes to luxury private jets, the Gulfstream G650 is often regarded as one of the best in its class. With its sleek design, advanced technology, and exceptional performance capabilities, this aircraft stands out from its competitors...Nov 3, 2023 · Illumina has 5 employees across 18 locations and $4.58 b in annual revenue in FY 2022. See insights on Illumina including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

GRAIL and Illumina are not competitors—this is a vertical acquisition. Based on past experience, when Illumina enters a market, the market expands. When Illumina entered the non-invasive prenatal testing space, prices dropped, reimbursement expanded, the number of providers increased, and more expectant parents had access to testing.

Nov 30, 2023 · See the latest Illumina Inc stock price (ILMN:XNAS), related news, valuation, ... Competitors . Guardant Health Inc. GH Exact Sciences Corp. EXAS Thermo Fisher Scientific Inc. TMO Don’t count the sequencing giant Illumina out just yet. Its scientists “probably have kept a couple of cards in their back pocket” to keep their position in the market strong, says Albert Vilella, a bioinformatician and genomics consultant in Cambridge, England. Nonetheless, Illumina faces unprecedented competition, he adds.across difficult-to-sequence or repetitive genome regions. Illumina NGS offers the flexibility of variable insert sizes and read lengths (35–300 bp), allowing high resolution characterization of any genome. Analyze, Store, and Share in Illumina’s BaseSpace® Cloud Data analysis is an important factor to consider for sequencing applications.Intense competition: Illumina operates in a highly competitive industry, and there are numerous other firms, including established ones, offering sequencing products and services. The company faces intense competition from other leading companies such as Thermo Fisher Scientific, Qiagen, BGI, etc. This competition could threaten Illumina's ...T2 Biosystems main competitors are Illumina, Regeneron, and Sanofi Genzyme. Competitor Summary. See how T2 Biosystems compares to its main competitors: Sanofi Genzyme has the most employees (12,000). Employees at Illumina earn more than most of the competitors, with an average yearly salary of $94,044.

An Illumina competitor with a less-expensive price point unveiled new technology at a recent genome biology conference.

Illumina on Tuesday unveiled plans to cut costs in a bid to improve the DNA sequencing company’s shrinking margins. The plans aim to reduce Illumina’s annualized run rate expenses by more than ...

Agilent Technologies main competitors are Intuitive Surgical, Varian Medical Systems, and Genentech. Competitor Summary. See how Agilent Technologies compares to its main competitors: Medtronic has the most employees (104,950). Employees at Intuitive Surgical earn more than most of the competitors, with an average yearly salary …16 dic 2022 ... ... competition to the industry. Between 80-90% of the sequencing market is dominated by one company, Illumina. The short-read sequencing ...3 mar 2023 ... “Illumina in 2010 released a machine enabling genome sequencing ... The large market potential is drawing well‐​financed competitors to Illumina.Illumina has disproportionately benefited from lower genome costs by keeping its clients’ total cost of ownership below that of its competitors. In some ways, Illumina can be compared to Nvidia ...Yes, Illumina and Affymetrix are competitors, but only in the DNA microarray business because that's the original business of Illumina before their purchase of the sequencing company Solexa in 2007.

Integra LifeSciences main competitors are Intuitive Surgical, Genentech, and Illumina. Competitor Summary. See how Integra LifeSciences compares to its main competitors: Medtronic has the most employees (104,950). Employees at Intuitive Surgical earn more than most of the competitors, with an average yearly salary of $113,813.ILMN Earnings Date and Information. Illumina last released its quarterly earnings results on November 9th, 2023. The life sciences company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.20. The company earned $1.12 billion during the quarter, compared to analysts' expectations of $1.13 billion.Thermo Fisher Scientific's top competitors include Illumina, Danaher and Boston Scientific. See the full list of Thermo Fisher Scientific alternatives and competitive updates on Owler, the world’s largest community-based business insights platform. Since early 2021, the agency has aired worries that Illumina could be tempted to throttle back the research of potential competitors, should it take full ownership of Grail. Illumina had ...At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high ...

This increased competition could potentially impact Illumina's market share and pricing power. Investing in Illumina involves risks associated with the healthcare industry, including regulatory changes, reimbursement challenges, and the need for continuous innovation to stay ahead of competitors.

454 Life Sciences main competitors are Guardant Health, Illumina, and Emergent BioSolutions. Competitor Summary. See how 454 Life Sciences compares to its main competitors: Illumina has the most employees (7,800). Employees at Guardant Health earn more than most of the competitors, with an average yearly salary of $103,078.Agilent Technologies main competitors are Intuitive Surgical, Varian Medical Systems, and Genentech. Competitor Summary. See how Agilent Technologies compares to its main competitors: Medtronic has the most employees (104,950). Employees at Intuitive Surgical earn more than most of the competitors, with an average yearly salary of $113,813.Employees at Illumina rank Francis deSouza in the Top 10% of CEOs in San Diego. Similarly, employees at Danaher rank Rainer Blair in the Top 15% of CEOs in Washington, DC. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.Medimmune main competitors are Genentech, Illumina, and PacBio. Competitor Summary. See how Medimmune compares to its main competitors: Genentech has the most employees (13,638). Employees at Genentech earn more than most of the competitors, with an average yearly salary of $97,473. The oldest company …Nov 29, 2023 · Personalis main competitors are Illumina, Zymergen, and PacBio. Competitor Summary. See how Personalis compares to its main competitors: Illumina has the most employees (7,800). Employees at Illumina earn more than most of the competitors, with an average yearly salary of $94,044. The oldest company is Illumina, founded in 1998. Apr 8, 2023 · Illumina. Market Cap. $17B. Today's Change. (7.69%) $7.84. Current Price. $109.79. Price as of December 1, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from ... Competition is intensifying in the DNA sequencing industry, which has long been dominated by sequencing behemoth Illumina. Driving the news: Illumina, which …Next generation sequencing (NGS) technology has revolutionized genomic and genetic research. The pace of change in this area is rapid with three major new sequencing platforms having been released in 2011: Ion Torrent’s PGM, Pacific Biosciences’ RS and the Illumina MiSeq. Here we compare the results obtained with those platforms …While NGS-based MECD technology is a nascent industry, it is expected to be a EUR 40 billion market by 2035. Given the ongoing innovation race between GRAIL and its competitors, Illumina would have a strong incentive to foreclose GRAIL’s rivals even though the benefits of doing so would only materialise in the future.

Intense competition: Illumina operates in a highly competitive industry, and there are numerous other firms, including established ones, offering sequencing products and services. The company faces intense competition from other leading companies such as Thermo Fisher Scientific, Qiagen, BGI, etc. This competition could threaten Illumina's ...

Illumina has had a great run, but competition is heating up. You forget Oxford Nanopore Technologies (ONT) under the competitors. More than Pacbio's, ONT's long read sequencing technology has a good chance of displacing Illumina's for many key applications.

Illumina has had a great run, but competition is heating up. You forget Oxford Nanopore Technologies (ONT) under the competitors. More than Pacbio's, ONT's long read sequencing technology has a good chance of displacing Illumina's for many key applications.Illumina 's top competitors include Algorithmic Biologics, P4 Medical Laboratory, and Beacon Biomedical. AB Algorithmic Biologics Analyst Briefing Submitted Algorithmic …Illumina was founded in 1998 and now controls over 80% of the sequencing market. The company reported a 2021 revenue of $4.526 billion and a market cap of …The main competitors of Agilent Technologies include Mettler-Toledo International (MTD), AMETEK (AME), Datadog (DDOG), Cognizant Technology Solutions (CTSH), CoStar Group (CSGP), Trade Desk (TTD), Fortinet (FTNT), Orange (ORAN), TE Connectivity (TEL), and STMicroelectronics (STM). These companies are all part of the "computer and technology ... Illumina is the market leader in the DNA sequencing industry. ... given the relevance of this industry Illumina will have to face competition from new and innovative technologies and withstand the ...Sanofi Genzyme main competitors are Gilead Sciences, Genentech, and Illumina. Competitor Summary. See how Sanofi Genzyme compares to its main competitors: Johnson & Johnson has the most employees (134,500). Employees at Gilead Sciences earn more than most of the competitors, with an average yearly salary of $99,828.significantly impede effective competition in the internal market. The General Court then proceeded to examine and reject other arguments raised by Illumina and Grail, notably that the Commission's interpretation and implementation of Article 22 in this case was in breach of the EU law principle of subsidiarity.Sep 30, 2022 · Illumina was founded in 1998 and now controls over 80% of the sequencing market. The company reported a 2021 revenue of $4.526 billion and a market cap of $28.92 billion as of September. Illumina's products are used in a variety of applications, including diagnostics, cancer research, drug development and agricultural biotechnology.

Agilent Technologies main competitors are Intuitive Surgical, Varian Medical Systems, and Genentech. Competitor Summary. See how Agilent Technologies compares to its main competitors: Medtronic has the most employees (104,950). Employees at Intuitive Surgical earn more than most of the competitors, with an average yearly salary …Nov 26, 2023 · Asuragen main competitors are Crunchbase, Blurb, and Intuit. Competitor Summary. See how Asuragen compares to its main competitors: Alphabet has the most employees (156,301). Employees at Crunchbase earn more than most of the competitors, with an average yearly salary of $149,168. The oldest company is Baker & Taylor, founded in 1828. HTG Molecular Diagnostics competitors are Halozyme, HTG Molecular Diagnostics, Illumina, and more. Learn more about HTG Molecular Diagnostics's competitors and alternatives by exploring information about those companies.Instagram:https://instagram. sap nysebest brokers for metatrader 5stockpickerberry global group AIBioTech main competitors are Illumina, PacBio, and Regeneron. Competitor Summary. See how AIBioTech compares to its main competitors: Sanofi Genzyme has the most employees (12,000). Employees at Illumina earn more than most of the competitors, with an average yearly salary of $94,044. The oldest company is …Sanofi Genzyme main competitors are Gilead Sciences, Genentech, and Illumina. Competitor Summary. See how Sanofi Genzyme compares to its main competitors: Johnson & Johnson has the most employees (134,500). Employees at Gilead Sciences earn more than most of the competitors, with an average yearly salary of $99,828. pizza hut the colonysavvy insurance quotes Employees at Illumina rank Francis deSouza in the Top 10% of CEOs in San Diego. Similarly, employees at Danaher rank Rainer Blair in the Top 15% of CEOs in Washington, DC. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results. utli GRAIL and Illumina are not competitors—this is a vertical acquisition. Based on past experience, when Illumina enters a market, the market expands. When Illumina entered the non-invasive prenatal testing space, prices dropped, reimbursement expanded, the number of providers increased, and more expectant parents had access to testing.Dec 1, 2023 · 17 equities research analysts have issued 1 year price targets for Illumina's shares. Their ILMN share price targets range from $100.00 to $328.00. On average, they predict the company's share price to reach $194.56 in the next year. This suggests a possible upside of 77.2% from the stock's current price.